Faculty of Education and Sports, Guangdong Baiyun University, Guangzhou, China.
School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin, China.
J Med Virol. 2020 Sep;92(9):1542-1548. doi: 10.1002/jmv.25768. Epub 2020 Mar 29.
During an outbreak of respiratory diseases including atypical pneumonia in Wuhan, a previously unknown β-coronavirus was detected in patients. The newly discovered coronavirus is similar to some β-coronaviruses found in bats but different from previously known SARS-CoV and MERS-CoV. High sequence identities and similarities between 2019-nCoV and SARS-CoV were found. In this study, we searched the homologous templates of all nonstructural and structural proteins of 2019-nCoV. Among the nonstructural proteins, the leader protein (nsp1), the papain-like protease (nsp3), the nsp4, the 3C-like protease (nsp5), the nsp7, the nsp8, the nsp9, the nsp10, the RNA-directed RNA polymerase (nsp12), the helicase (nsp13), the guanine-N7 methyltransferase (nsp14), the uridylate-specific endoribonuclease (nsp15), the 2'-O-methyltransferase (nsp16), and the ORF7a protein could be built on the basis of homology templates. Among the structural proteins, the spike protein (S-protein), the envelope protein (E-protein), and the nucleocapsid protein (N-protein) can be constructed based on the crystal structures of the proteins from SARS-CoV. It is known that PL-Pro, 3CL-Pro, and RdRp are important targets for design antiviral drugs against 2019-nCoV. And S protein is a critical target candidate for inhibitor screening or vaccine design against 2019-nCoV because coronavirus replication is initiated by the binding of S protein to cell surface receptors. It is believed that these proteins should be useful for further structure-based virtual screening and related computer-aided drug development and vaccine design.
在武汉发生包括非典型肺炎在内的呼吸道疾病爆发期间,在患者中检测到一种以前未知的β冠状病毒。新发现的冠状病毒与在蝙蝠中发现的一些β冠状病毒相似,但与以前已知的 SARS-CoV 和 MERS-CoV 不同。在这项研究中,我们搜索了 2019-nCoV 的所有非结构和结构蛋白的同源模板。在非结构蛋白中,发现 2019-nCoV 的 nsp1、nsp3、nsp4、nsp5、nsp7、nsp8、nsp9、nsp10、nsp12、nsp13、nsp14、nsp15、nsp16 和 ORF7a 蛋白的先导蛋白(nsp1)、木瓜蛋白酶样蛋白酶(nsp3)、nsp4、3C 样蛋白酶(nsp5)、nsp7、nsp8、nsp9、nsp10、nsp12、nsp13、nsp14、nsp15、nsp16 和 ORF7a 蛋白可以根据同源模板构建。在结构蛋白中,刺突蛋白(S 蛋白)、包膜蛋白(E 蛋白)和核衣壳蛋白(N 蛋白)可以根据 SARS-CoV 蛋白的晶体结构构建。已知 PL-Pro、3CL-Pro 和 RdRp 是设计针对 2019-nCoV 的抗病毒药物的重要靶点。S 蛋白是针对 2019-nCoV 抑制剂筛选或疫苗设计的关键候选靶标,因为冠状病毒的复制是由 S 蛋白与细胞表面受体的结合引发的。人们相信这些蛋白应该对进一步的基于结构的虚拟筛选以及相关的计算机辅助药物开发和疫苗设计有用。